SCHEMBL7793469

SCHEMBL7793469

CCC(C)N(C(=O)c1cnc2c3c(ccc2c1)C(=O)C([N+](=O)[O-])C=N3)C(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799067 0.84 HCAR3 (0.33)
SCHEMBL6985187 0.82 PSMD14 (0.40)
SCHEMBL6981930 0.82 MAOB (0.43)
SCHEMBL7802370 0.81 ADORA2A (0.37)
SCHEMBL7799351 0.79 RAB9A (0.37)
SCHEMBL7801071 0.73 LRRK2 (0.33)
SCHEMBL7799355 0.72 HPGD (0.34)
SCHEMBL8437417 0.69 HCAR3 (0.33)
SCHEMBL7799131 0.69 PDK2 (0.36)
SCHEMBL7801055 0.68 HPGD (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999021860-B1 PHENANTHROLINE DERIVATIVES FIBROGEN INC (US) 1999-08-05 WO claimed
US-20010001101-A1 Phenanthroline derivatives ZENECA LIMITED 2001-05-10 US disclosed
EP-1027351-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 2000-08-16 EP disclosed
WO-1999021860-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 1999-05-06 WO disclosed